MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cnbc'. Sat, 03 Sep 2011 02:20:30 +0100 http://www.medworm.com/index.php?rid=3753782&cid=t_117711_87_f&fid=36050&url=http%3A%2F%2Fblisstree.com%2Flive%2Fj-r-ewing-is-back-selling-green-energy-not-oil%2F If you were a fan of Dallas back in the day (and who wasn’t?), you know that J.R. Ewing as a big-wig oil tycoon who only associated the color green with money – and got shot. But now, J.R.’s back, singing the praises of green living through solar energy in a commercial for SolarWorld. Check out the commercial here, and an interview with Larry Hagman (the man behind J.R.), at his real-life solar powered mansion, below. Perhaps next, Homer Simpson will convince Mr. Burns to convert the nuclear power plant into a wind farm. via The New York Times Post from: BlissTree J.R. Ewing Is Back: Selling Green Energy, Not Oil (Source: Breastfeeding 1-2-3) Breastfeeding 1-2-3 blogs http://www.medworm.com/rss/comments.php?id=3753782 Wed, 14 Jul 2010 18:34:47 +0100 3753782 http://www.medworm.com/index.php?rid=3658934&cid=t_117711_87_f&fid=36050&url=http%3A%2F%2Fblisstree.com%2Flive%2Fexclusive-mediabistro-com-founder-laurel-touby-on-making-millions-marriage-and-moving-forward%2F Laurel Touby and husband Jon Fine at the Webutante Ball in NYC, June 8, 2010 A former freelance writer, Laurel Touby came up with the idea for her influential media company, Mediabistro.com, in 1994, and in 2007, sold it for a cool $23 million. (She didn’t pocket all of that, though.) Just back from an eight-month international sabbatical, Laurel took some time out to answer our 11 questions about marriage, making more money than her husband, and moving on after major success. Long before you sold Mediabistro (the company you founded) for many millions of dollars, did you care who made more money, you or your then-boyfriend? I would love to say that it didn’t matter, because I’m an emancipated woman who went to Smith College. But, it was nice to know that he could pay his part of... Breastfeeding 1-2-3 blogs http://www.medworm.com/rss/comments.php?id=3658934 Mon, 14 Jun 2010 14:30:40 +0100 3658934 http://www.medworm.com/index.php?rid=2916081&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FziYjmUwKyB8%2F According to reports, executives from bailed out companies Citigroup, Bank of America, GM, Chrysler, GMAC, Chrysler Financial and AIG are going to see major pay cuts this year, which will be enforced by the president’s “pay czar,” Kenneth R. Feinberg. WaPo: NEW YORK — The Obama administration plans to order companies that have received exceptionally large amounts of bailout money from the government to slash compensation for their highest-paid executives by about half on average, according to people familiar with the long-awaited decision. The administration will also curtail many corporate perks, including the use of corporate jets for personal travel, chauffeured drivers and country club fee reimbursement, people familiar with the matter have said. Individual per... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2916081 Thu, 22 Oct 2009 14:30:50 +0100 2916081 http://www.medworm.com/index.php?rid=2890619&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FbEEDdrCMNx8%2F How to measure the effectiveness of Obama’s stimulus plan. Forbes: The CBO estimate of the number of people who would stop being uninsured under the Senate Finance Committee proposal is exaggerated by at least 7 million to 10 million. Smoke and mirrors within the Senate Finance Committee? How to save democracy in Honduras. Video: Economist Daniel J. Mitchell discusses economic reform on CNBC. (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2890619 Tue, 13 Oct 2009 21:09:16 +0100 2890619 http://www.medworm.com/index.php?rid=2865648&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FOU8VBlIASEw%2F Did you know that the average American family spends $1,000 each year on the U.S. Department of Agriculture, whether or not it consumes that agency’s services?  Or that the federal government annually spends $1,500 per household on net interest costs alone? In an ongoing effort to shed light on runaway government spending and expose wasteful government programs, Cato launched a new Web site today that examines the federal budget department-by-department to see which agencies can be reformed or terminated. DownsizingGovernment.org describes which programs are wasteful, damaging and obsolete in an era of trillion-dollar deficits. The research exposes that many public outlays—though vigorously defended by the politicians who created them and the constituencies they purport to help... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2865648 Mon, 05 Oct 2009 18:59:26 +0100 2865648 http://www.medworm.com/index.php?rid=2820196&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2Fi6DXsCi_97M%2F The good folks over at Freedom to Trade recently filmed an interview with me about the implications of the China tire tariffs: And if you just can’t get enough about the ramifications of the tire tariff, check out this Canadian Business News clip from yesterday, or this one from CNBC today. (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2820196 Tue, 22 Sep 2009 16:04:57 +0100 2820196 http://www.medworm.com/index.php?rid=2424494&cid=t_117711_150_f&fid=38374&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FePharmaSummit%2F%7E3%2FuA0tX_iql10%2Fcnbc-gsk-pharmas-foray-into-blogosphere.html (Source: ePharma Summit) ePharma Summit blogs http://www.medworm.com/rss/comments.php?id=2424494 Wed, 20 May 2009 14:04:00 +0100 2424494 http://www.medworm.com/index.php?rid=2405036&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F3K8wIIN2shw%2F That’s an apt way to describe this week’s health-care-reform media blitz by the White House. It’s probably also a good way to describe this debate over that media blitz: (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2405036 Wed, 13 May 2009 15:50:51 +0100 2405036 http://www.medworm.com/index.php?rid=2375847&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FHCqoRE_cuhg%2F Here are a few highlights from Cato Today, a daily email from the Cato Institute. Dan Ikenson and Scott Lincicome argue in a new study that restoring the pro-trade consensus must be a top priority for the Obama administration. In the DC Examiner, Gene Healy discusses Obama’s first 100 days and argues that he’s massively expanded the power of government in a short period of time. In the Asia Times Online, David Isenberg discusses private security contractors in the war in Iraq. Watch Patrick J. Michaels discuss energy on CNBC. In Tuesday’s Cato Daily Podcast, Peter Van Doren discusses the interaction between Congress and regulators on the issue of food safety. (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2375847 Tue, 28 Apr 2009 21:07:20 +0100 2375847 http://www.medworm.com/index.php?rid=2353751&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FiYgnwokLoPs%2F Health care, Jonathan Cohn, and me.  All in one place on CNBC at 8pm tonight. (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2353751 Tue, 21 Apr 2009 20:16:11 +0100 2353751 http://www.medworm.com/index.php?rid=2306729&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2F24LVmhFGt18%2F G-20 Summit Agrees to International Spending Plan The Washington Post reports, “Leaders from more than 20 major nations including the United States decided Thursday to make available an additional $1 trillion for the world economy through the International Monetary Fund and other institutions as part of a broad package of measures to overcome the global financial crisis.” Cato scholars Richard W. Rahn, Daniel J. Ikenson and Ian Vásquez commented on the London-based meeting: Rahn: “President Obama of the U.S. and Prime Minister Brown of the U.K. will be pressing for more so-called stimulus spending by other nations, despite the fact that the historical evidence shows that big increases in government spending are more likely to be damaging and slow down recovery than they ... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2306729 Fri, 03 Apr 2009 21:32:27 +0100 2306729 http://www.medworm.com/index.php?rid=2255981&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FtviCb3eW8cA%2F In a CNBC spot with Steve Liesman & Erin Burnett, I tried to explain why investors in bank stocks had good reason to be pleased with part of Fed Chairman Ben Bernanke’s speech.  Judging by the response of Steve and Erin, and others on CNBC over the following day,  I must not have been persuasive. For clarification, I am quoting the exact language from Bernanke’s talk, with my emphasis added. My main point is that Bernanke admitted that when it comes to the “financial crisis” of some big banks, this is largely an artifact of unduly harsh regulation being applied at the worst possible time: There is some evidence that capital standards, accounting rules, and other regulations have made the financial sector excessively procyclical–that is, they lead financial insti... Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2255981 Wed, 11 Mar 2009 19:27:45 +0100 2255981 http://www.medworm.com/index.php?rid=2211759&cid=t_117711_87_f&fid=36438&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FCato-at-liberty%2F%7E3%2FPIJezssGnLc%2F Cato Executive Vice President David Boaz debates Heather Boushey, senior economist at the Center for American Progress, over the legacies of Presidents Franklin Roosevelt and Ronald Reagan. In light of the current economic crisis, who serves as the better role model for President Obama? For more videos, subscribe to Cato’s YouTube channel. (Source: Cato-at-liberty) Cato-at-liberty blogs http://www.medworm.com/rss/comments.php?id=2211759 Mon, 23 Feb 2009 16:13:08 +0100 2211759 http://www.medworm.com/index.php?rid=1488658&cid=t_117711_109_f&fid=35677&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainBasedBusiness%2F%7E3%2F303340338%2Fbrainy_money_tips_at_cnbc_tv18.html Congratulations to colleague, Sita Menon, for an exciting new enterprise over at CNBC – TV18 in India. The site’s vision rests on a quote from Robert Noyce, a founder at Intel … Start with a growing market. Swim in a stream that becomes a river and ultimately an ocean. Be a leader in that market, not a follower, and constantly build the best products possible.”What refreshing new windows into financial well-being and career growth! Hopefully we’ll also see neuroscience discoveries of growing connections between wealth and the brain at work, and I suspect we will. Most would agree that not everyone has the vision, for wealth that’s natural and wealth that’s fun. Yet I’ve been especially struck by wit and wisdom t... BrainBasedBusiness blogs http://www.medworm.com/rss/comments.php?id=1488658 Tue, 03 Jun 2008 01:40:05 +0100 1488658 http://www.medworm.com/index.php?rid=1277856&cid=t_117711_150_f&fid=34768&url=http%3A%2F%2Fpharmagossip.blogspot.com%2F2008%2F03%2Fquote-of-week-from-cnbcs-mike-huckman.html All I ask--all I think any reporter asks--is that corporate PR people shoot straight. Be up front. Don't lie. I still think I'm being penalized for asking Mr. Kindler in late 2006 how he goes from selling chicken as the head of "Boston Market" to running the world's biggest pharmaceutical company. Source (Source: PharmaGossip) PharmaGossip blogs http://www.medworm.com/rss/comments.php?id=1277856 Tue, 04 Mar 2008 17:19:00 +0100 1277856 http://www.medworm.com/index.php?rid=805911&cid=t_117711_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F08%2F17%2Foral-lyn-has-the-big-idea%2F Filed under: Type 1, Type 2, Childhood, Adult Onset, Drugs, Research, Products, Allie BeattyThe results are looking good for the first-round of human testing for Oral-lyn, Generex's flagship product. The oral insulin, delivered into the body through the oral cavity (with no deposit in the lungs), is as effective as injected insulin. The efficacy of Oral-lyn for controlling blood sugar was decidedly as good as multiple insulin injections. The research found that regular insulin and Generex Oral-lyn had similar effects on lowering blood sugar in subjects with type 1 diabetes. The subjects received twice-daily insulin analogue for basal coverage. So this might rewind some of us old timers to the days long-gone where we could get by with two shots. Period. If Oral-lyn makes it to the local pha... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=805911 Fri, 17 Aug 2007 04:00:00 +0100 805911 http://www.medworm.com/index.php?rid=801644&cid=t_117711_150_f&fid=35777&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F144427013%2F What’s wrong with the FDA? Are safety concerns emphasized at the expense of needed therapies? Are drugs approved too quickly or not fast enough? And whatever your view, who’s to blame? A recent segment on CNBC’s Squawkbox tries to sort it out with help from Joel Sendek, a Lazard Capital Markets managing director and biotech analyst, and Paul Brown, a consumer healthcare advociate with the Public Interest Research Group. Click on this link to watch the video. Share / E-mail (Source: Pharmalot) Pharmalot blogs http://www.medworm.com/rss/comments.php?id=801644 Wed, 15 Aug 2007 15:09:09 +0100 801644 http://www.medworm.com/index.php?rid=612021&cid=t_117711_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F14%2Fmad-money-says-novo-nordisk-sell-sell-sell%2F Filed under: Type 1, Type 2, Childhood, Adult Onset, Drugs, Research, Daily News, OpinionMad Money is a stock show on CNBC hosted by Jim Cramer - a well-known iron fist on Wall Street. He has a following of stock enthusiasts who regard his recommendations (buy or sell) as gospel. Why is he so good at what he does? He just wants to help you make money. And to this end -- the reason I bring Cramer's passionate drive to The Diabetes Blog is simple: last week he called Novo Nordisk as a SELL. Cramer said he's beginning to worry about a backlash on drug stocks. He advised that viewers should not be greedy and should take gains in Novo Nordisk (NVO). Perhaps the NY Times article raised some eyebrows at Big Pharma. It appears doctors are receiving handsome gifts and stipends for handing out samp... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=612021 Mon, 14 May 2007 04:00:00 +0100 612021 http://www.medworm.com/index.php?rid=601903&cid=t_117711_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F11%2F120-million-to-stop-the-spread%2F Filed under: Type 2, Adult Onset, Diet, Lifestyle, Research, Exercise, Daily News, SupportDiabetes is making a name for itself and it's spreading like wildfire. Politicians are uniting to build a $120 million campaign to educate diabetics to prevent the spread of the disease and its complications. Senator Clinton criticizes the reaction to the problem, rather than taking measures to prevent it from occurring. She questions why current money is unquestionably $pent on treating complications from diabetes -- such as amputations and dialysis. Good point, Senator. Ask Bush if he's got any friends up at Eli Lilly. A good answer can always be found in a temporary restraining order. She and fellow politicians propose more money be spent on programs for weight-loss, nutrition education and other ... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=601903 Fri, 11 May 2007 04:00:00 +0100 601903 http://www.medworm.com/index.php?rid=601902&cid=t_117711_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F05%2F11%2Fmuscle-for-rank-in-the-continuous-glucose-monitoring-market%2F Filed under: Type 1, Type 2, Childhood, Adult Onset, Lifestyle, Research, Opinion, Products, SupportIn the next 3 to 5 years, we will have a new generation of control upon us providing continuous glucose monitoring. Some of these marvelous technologies will not require a drop of blood, while others will embody the tried-and-true stick-to-itiveness we all know and loathe. Please join me as we browse the isles of things to come (and things now available) for continuous glucose monitoring. The DexCom STS Continuous Glucose Monitoring System is a glucose sensor that reports glucose values every 5 minutes for up to 72 hours. The sensor is inserted in the abdomen. After a 2 hour start-up period, the STS System is calibrated with 2 fingerstick measurements taken by a traditional glucose meter. ... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=601902 Fri, 11 May 2007 04:00:00 +0100 601902 http://www.medworm.com/index.php?rid=541236&cid=t_117711_87_f&fid=34867&url=http%3A%2F%2Fwww.thediabetesblog.com%2F2007%2F04%2F13%2Fada-response-back-and-forthcoming%2F Filed under: Type 1, Childhood, Adult Onset, Daily News, Events, Opinion, SupportFair and balanced, just like Fox News -- I want to let everyone know that the "Matt P" I spoke to, at the ADA responded to my blog about the aforementioned conversation. His response is #17 and it is sincere and genuine -- certifiable in my book. Again, let me reiterate that the nature of my call to the ADA was to ask for their assistance in getting a big pharmaceutical company to sponsor C-peptide FDA trials here in the US. Thanks again to Matt. He really is doing all he can, but there seems to be a suspicious roadblock holding up the research here in the US. Any guesses? Without further adieu, here's Matt: I hope people will take time to read my reply to yesterday's post about ADA and c-peptide. I work for A... The Diabetes Blog blogs http://www.medworm.com/rss/comments.php?id=541236 Fri, 13 Apr 2007 04:00:00 +0100 541236